Eledon Pharmaceuticals (ELDN) Stocktwits Mentions Statistics 2025

10%

1W 0% 1M 0% 3M 66.7%

Est. daily mentions on Stocktwits.

Similar companies

Company		Stocktwits Mentions
	Amgen AMGN	40 4.8%
	Gilead Sciences GILD	37 24.5%
	Catalyst Pharmaceuticals CPRX	8 38.5%
	Inovio Pharmaceuticals INO	213 13.1%
	Anavex Life Sciences AVXL	288 13%

Month over Month

Est. daily mentions on Stocktwits.

Mar 2025	1	75.5%
Feb 2025	5	67.8%
Jan 2025	3	39.1%
Dec 2024	5	40.8%
Nov 2024	9

How often is Eledon Pharmaceuticals mentioned on StockTwits?

Eledon Pharmaceuticals was mentioned an estimated 1 times in discussions on StockTwits yesterday.

Analyzing Stocktwits Mentions, how is Eledon Pharmaceuticals performing compared to its industry peers?

Eledon Pharmaceuticals underperforms its industry peers when it comes to Stocktwits Mentions, ranking dead last.

What does a high frequency of StockTwits mentions indicate for Eledon Pharmaceuticals' market sentiment?

A high frequency of mentions on StockTwits for Eledon Pharmaceuticals could indicate strong market interest or sentiment towards the company. It often reflects the trading community's engagement with Eledon Pharmaceuticals' stock, potentially signaling bullish or bearish trends based on the context of the discussions.

How often does AltIndex update information on Eledon Pharmaceuticals' mentions on StockTwits?

AltIndex updates the data on Eledon Pharmaceuticals' mentions on StockTwits daily. This frequent update schedule ensures that investors have access to the most current insights into market sentiment and discussion dynamics related to Eledon Pharmaceuticals' on the platform.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.